1 Study Coverage 1.1 CAR T-Cell Therapy Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Introduction 1.2 Global CAR T-Cell Therapy Outlook 2017 VS 2022 VS 2028 1.2.1 Global CAR T-Cell Therapy Market Size for the Year 2017-2028 1.2.2 Global CAR T-Cell Therapy Market Size for the Year 2017-2028 1.3 CAR T-Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States CAR T-Cell Therapy in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of CAR T-Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 CAR T-Cell Therapy Market Dynamics 1.4.1 CAR T-Cell Therapy Industry Trends 1.4.2 CAR T-Cell Therapy Market Drivers 1.4.3 CAR T-Cell Therapy Market Challenges 1.4.4 CAR T-Cell Therapy Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 CAR T-Cell Therapy by Type 2.1 CAR T-Cell Therapy Market Segment by Type 2.1.1 Allogeneic 2.1.2 Autologous 2.2 Global CAR T-Cell Therapy Market Size by Type (2017, 2022 & 2028) 2.3 Global CAR T-Cell Therapy Market Size by Type (2017-2028) 2.4 United States CAR T-Cell Therapy Market Size by Type (2017, 2022 & 2028) 2.5 United States CAR T-Cell Therapy Market Size by Type (2017-2028) 3 CAR T-Cell Therapy by Application 3.1 CAR T-Cell Therapy Market Segment by Application 3.1.1 Hospitals 3.1.2 Cancer Research Centers 3.1.3 Others 3.2 Global CAR T-Cell Therapy Market Size by Application (2017, 2022 & 2028) 3.3 Global CAR T-Cell Therapy Market Size by Application (2017-2028) 3.4 United States CAR T-Cell Therapy Market Size by Application (2017, 2022 & 2028) 3.5 United States CAR T-Cell Therapy Market Size by Application (2017-2028) 4 Global CAR T-Cell Therapy Competitor Landscape by Company 4.1 Global CAR T-Cell Therapy Market Size by Company 4.1.1 Top Global CAR T-Cell Therapy Companies Ranked by Revenue (2021) 4.1.2 Global CAR T-Cell Therapy Revenue by Player (2017-2022) 4.2 Global CAR T-Cell Therapy Concentration Ratio (CR) 4.2.1 CAR T-Cell Therapy Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of CAR T-Cell Therapy in 2021 4.2.3 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global CAR T-Cell Therapy Headquarters, Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type 4.3.1 Global CAR T-Cell Therapy Headquarters and Area Served 4.3.2 Global CAR T-Cell Therapy Companies Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into CAR T-Cell Therapy Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States CAR T-Cell Therapy Market Size by Company 4.5.1 Top CAR T-Cell Therapy Players in United States, Ranked by Revenue (2021) 4.5.2 United States CAR T-Cell Therapy Revenue by Players (2020, 2021 & 2022) 5 Global CAR T-Cell Therapy Market Size by Region 5.1 Global CAR T-Cell Therapy Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global CAR T-Cell Therapy Market Size by Region (2017-2028) 5.2.1 Global CAR T-Cell Therapy Market Size by Region: 2017-2022 5.2.2 Global CAR T-Cell Therapy Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America CAR T-Cell Therapy Market Size YoY Growth 2017-2028 6.1.2 North America CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific CAR T-Cell Therapy Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific CAR T-Cell Therapy Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe CAR T-Cell Therapy Market Size YoY Growth 2017-2028 6.3.2 Europe CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America CAR T-Cell Therapy Market Size YoY Growth 2017-2028 6.4.2 Latin America CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa CAR T-Cell Therapy Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Celgene (Juno Therapeutics) 7.1.1 Celgene (Juno Therapeutics) Company Details 7.1.2 Celgene (Juno Therapeutics) Business Overview 7.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction 7.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022) 7.1.5 Celgene (Juno Therapeutics) Recent Development 7.2 Novartis 7.2.1 Novartis Company Details 7.2.2 Novartis Business Overview 7.2.3 Novartis CAR T-Cell Therapy Introduction 7.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) 7.2.5 Novartis Recent Development 7.3 Gilead (Kite Pharma) 7.3.1 Gilead (Kite Pharma) Company Details 7.3.2 Gilead (Kite Pharma) Business Overview 7.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction 7.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022) 7.3.5 Gilead (Kite Pharma) Recent Development 7.4 Pfizer 7.4.1 Pfizer Company Details 7.4.2 Pfizer Business Overview 7.4.3 Pfizer CAR T-Cell Therapy Introduction 7.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022) 7.4.5 Pfizer Recent Development 7.5 CARsgen Therapeutics 7.5.1 CARsgen Therapeutics Company Details 7.5.2 CARsgen Therapeutics Business Overview 7.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction 7.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) 7.5.5 CARsgen Therapeutics Recent Development 7.6 Autolus Therapeutics 7.6.1 Autolus Therapeutics Company Details 7.6.2 Autolus Therapeutics Business Overview 7.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction 7.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) 7.6.5 Autolus Therapeutics Recent Development 7.7 Aurora BioPharma 7.7.1 Aurora BioPharma Company Details 7.7.2 Aurora BioPharma Business Overview 7.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction 7.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022) 7.7.5 Aurora BioPharma Recent Development 7.8 Sorrento Therapeutics 7.8.1 Sorrento Therapeutics Company Details 7.8.2 Sorrento Therapeutics Business Overview 7.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction 7.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) 7.8.5 Sorrento Therapeutics Recent Development 7.9 Mustang Bio 7.9.1 Mustang Bio Company Details 7.9.2 Mustang Bio Business Overview 7.9.3 Mustang Bio CAR T-Cell Therapy Introduction 7.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022) 7.9.5 Mustang Bio Recent Development 7.10 Bluebird Bio 7.10.1 Bluebird Bio Company Details 7.10.2 Bluebird Bio Business Overview 7.10.3 Bluebird Bio CAR T-Cell Therapy Introduction 7.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022) 7.10.5 Bluebird Bio Recent Development 7.11 Collectis 7.11.1 Collectis Company Details 7.11.2 Collectis Business Overview 7.11.3 Collectis CAR T-Cell Therapy Introduction 7.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2017-2022) 7.11.5 Collectis Recent Development 7.12 Allogene Therapeutics 7.12.1 Allogene Therapeutics Company Details 7.12.2 Allogene Therapeutics Business Overview 7.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction 7.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) 7.12.5 Allogene Therapeutics Recent Development 7.13 Celyad 7.13.1 Celyad Company Details 7.13.2 Celyad Business Overview 7.13.3 Celyad CAR T-Cell Therapy Introduction 7.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2017-2022) 7.13.5 Celyad Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. CAR T-Cell Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. CAR T-Cell Therapy Market Trends Table 3. CAR T-Cell Therapy Market Drivers Table 4. CAR T-Cell Therapy Market Challenges Table 5. CAR T-Cell Therapy Market Restraints Table 6. Global CAR T-Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States CAR T-Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global CAR T-Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States CAR T-Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top CAR T-Cell Therapy Companies in Global Market, Ranking by Revenue (2021) Table 11. Global CAR T-Cell Therapy Revenue by Player, (US$ Million), 2017-2022 Table 12. Global CAR T-Cell Therapy Revenue Share by Player, 2017-2022 Table 13. Global CAR T-Cell Therapy Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021) Table 15. Top Players of CAR T-Cell Therapy in Global Market, Headquarters and Area Served Table 16. Companies Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into CAR T-Cell Therapy Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top CAR T-Cell Therapy Players in United States Market, Ranking by Revenue (2021) Table 20. United States CAR T-Cell Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States CAR T-Cell Therapy Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million) Table 24. Global CAR T-Cell Therapy Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific CAR T-Cell Therapy Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Celgene (Juno Therapeutics) Company Details Table 31. Celgene (Juno Therapeutics) Business Overview Table 32. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product Table 33. Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 34. Celgene (Juno Therapeutics) Recent Development Table 35. Novartis Company Details Table 36. Novartis Business Overview Table 37. Novartis CAR T-Cell Therapy Product Table 38. Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 39. Novartis Recent Development Table 40. Gilead (Kite Pharma) Company Details Table 41. Gilead (Kite Pharma) Business Overview Table 42. Gilead (Kite Pharma) CAR T-Cell Therapy Product Table 43. Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 44. Gilead (Kite Pharma) Recent Development Table 45. Pfizer Company Details Table 46. Pfizer Business Overview Table 47. Pfizer CAR T-Cell Therapy Product Table 48. Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 49. Pfizer Recent Development Table 50. CARsgen Therapeutics Company Details Table 51. CARsgen Therapeutics Business Overview Table 52. CARsgen Therapeutics CAR T-Cell Therapy Product Table 53. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 54. CARsgen Therapeutics Recent Development Table 55. Autolus Therapeutics Company Details Table 56. Autolus Therapeutics Business Overview Table 57. Autolus Therapeutics CAR T-Cell Therapy Product Table 58. Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 59. Autolus Therapeutics Recent Development Table 60. Aurora BioPharma Company Details Table 61. Aurora BioPharma Business Overview Table 62. Aurora BioPharma CAR T-Cell Therapy Product Table 63. Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 64. Aurora BioPharma Recent Development Table 65. Sorrento Therapeutics Company Details Table 66. Sorrento Therapeutics Business Overview Table 67. Sorrento Therapeutics CAR T-Cell Therapy Product Table 68. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 69. Sorrento Therapeutics Recent Development Table 70. Mustang Bio Company Details Table 71. Mustang Bio Business Overview Table 72. Mustang Bio CAR T-Cell Therapy Product Table 73. Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 74. Mustang Bio Recent Development Table 75. Bluebird Bio Company Details Table 76. Bluebird Bio Business Overview Table 77. Bluebird Bio CAR T-Cell Therapy Product Table 78. Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 79. Bluebird Bio Recent Development Table 80. Collectis Company Details Table 81. Collectis Business Overview Table 82. Collectis CAR T-Cell Therapy Product Table 83. Collectis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 84. Collectis Recent Development Table 85. Allogene Therapeutics Company Details Table 86. Allogene Therapeutics Business Overview Table 87. Allogene Therapeutics CAR T-Cell Therapy Product Table 88. Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 89. Allogene Therapeutics Recent Development Table 90. Celyad Company Details Table 91. Celyad Business Overview Table 92. Celyad CAR T-Cell Therapy Product Table 93. Celyad Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Table 94. Celyad Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. CAR T-Cell Therapy Product Picture Figure 2. Global CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global CAR T-Cell Therapy Market Size 2017-2028 (US$ Million) Figure 4. United States CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States CAR T-Cell Therapy Market Size 2017-2028 (US$ Million) Figure 6. United States CAR T-Cell Therapy Market Share in Global 2017-2028 Figure 7. CAR T-Cell Therapy Report Years Considered Figure 8. Product Picture of Allogeneic Figure 9. Product Picture of Autologous Figure 10. Global CAR T-Cell Therapy Market Share by Type in 2022 & 2028 Figure 11. Global CAR T-Cell Therapy Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global CAR T-Cell Therapy Market Share by Type (2017-2028) Figure 13. United States CAR T-Cell Therapy Market Share by Type in 2022 & 2028 Figure 14. United States CAR T-Cell Therapy Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States CAR T-Cell Therapy Market Share by Type (2017-2028) Figure 16. Product Picture of Hospitals Figure 17. Product Picture of Cancer Research Centers Figure 18. Product Picture of Others Figure 19. Global CAR T-Cell Therapy Market Share by Application in 2022 & 2028 Figure 20. Global CAR T-Cell Therapy Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global CAR T-Cell Therapy Market Share by Application (2017-2028) Figure 22. United States CAR T-Cell Therapy Market Share by Application in 2022 & 2028 Figure 23. United States CAR T-Cell Therapy Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States CAR T-Cell Therapy Market Share by Application (2017-2028) Figure 25. North America CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Celgene (Juno Therapeutics) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 54. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 55. Gilead (Kite Pharma) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 56. Pfizer Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 57. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 58. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 59. Aurora BioPharma Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 60. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 61. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 62. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 63. Collectis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 64. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 65. Celyad Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Celgene (Juno Therapeutics) Novartis Gilead (Kite Pharma) Pfizer CARsgen Therapeutics Autolus Therapeutics Aurora BioPharma Sorrento Therapeutics Mustang Bio Bluebird Bio Collectis Allogene Therapeutics Celyad